If you are not happy with the results below please do another search
Canadian life sciences company Ondine Biomedical has presented new research showing that their Steriwave photodisinfection device reduced antibiotic-resistant bacteria by more than 99.9%. The in vitro study, presented at the IP2023 annual conference in Liverpool in October, shows that photodisinfection can play an important role in strategies for combatting antimicrobial resistance.
On 14 October 2023, the World Health Organization (WHO), through its Department of Maternal, Newborn, Child, and Adolescent Health and Ageing (MCA), and the European Geriatric Medicine Society (EuGMS) signed a three-year Memorandum of Understanding (MoU) to formalize a close collaboration and exchange aimed at improving care for healthy ageing.
Philips has received a second round of funding from the Bill & Melinda Gates Foundation to accelerate global adoption of AI algorithms on the Philips Lumify handheld ultrasound. By using AI to simplify key measurements to identify abnormalities during pregnancy, training time to use the ultrasound system can be reduced from weeks to just hours, […]
KeraLink International (KLI) has provided $2.5 million in seed funding for Pantheon Vision (PV) to launch the development of novel bioengineered corneal implants to help eradicate corneal blindness in both developed and low- and middle-income countries (LMICs).
AATec Medical, a biotech company developing a multi-product platform based on recombinant alpha-1 antitrypsin (AAT), and Beurer, a global manufacturer of products for healthcare, will collaborate to develop novel innovative inhaler devices. The new devices will be used in combination with AATec’s products for the treatment of respiratory diseases including acute respiratory distress syndrome (ARDS), […]
Siemens Healthineers and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), announced a partnership at the recent World Health Summit to accelerate the use of artificial intelligence (AI) in X-ray screening for tuberculosis (TB), a preventable, treatable, and curable infectious disease that is again on the rise globally.
In a significant financial milestone, Xlife Sciences has invested CHF23.3 million (US$26,3 million) in 4D Lifetec, acquiring a 20% stake in the company. With the agreement, Xlife Sciences is not only bringing in a direct cash investment, but also an AI software developed specifically for 4D Lifetec, which will massively expand the functionality of the […]
SOPHiA GENETICS, a global leader in data-driven medicine will collaborate with Memorial Sloan Kettering Cancer Center (MSK), a top cancer treatment and research institution, and AstraZeneca to advance health equity on a global scale by providing inclusive access to comprehensive cancer testing worldwide.
Royal Victoria Hospital (RVH), part of Belfast Health and Social Care Trust, and Siemens Healthineers have announced a multi-million-euro, 20-year agreement to streamline clinical workflows and boost patient care across Belfast and surrounding areas in Northern Ireland. In addition to equipment management, this Value Partnership contains elements such as programmes for clinical services optimization and […]
Owlstone Medical, a pioneer in breath biopsy for applications in early disease detection and precision medicine, has begun recruitment of patients into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1. The trial has been designed to support development of a breath test to […]
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.